NCT01612819终止不适用
Evaluation of Effectiveness and Safety of DXR(Previous Cilotax) Stent in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study (IRIS-CILOTAX)
Seung-Jung Park18 个研究点 分布在 1 个国家目标入组 451 人开始时间: 2012年4月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 451
- 试验地点
- 18
- 主要终点
- composite of death, nonfatal myocardial infarction (MI), or target- Vessel Revascularization (TVR)
研究概览
简要总结
Registry of cilotax stent(Dual drug eluting stent) implantation for CAD patients
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with significant coronary artery disease and receiving Cilotax (dual drug eluting stent)
- •The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
排除标准
- •Patients with a mixture of other DESs
- •Terminal illness with life expectancy <1 year
- •Patients presented with cardiogenic shock
结局指标
主要结局
composite of death, nonfatal myocardial infarction (MI), or target- Vessel Revascularization (TVR)
时间窗: at 12 months post procedure
次要结局
- Death (all cause and cardiac)(12 months and yearly up to 5 years)
- Myocardial Infarction(6 months)
- Procedural success(at day 1)
- Stent thrombosis(6 months)
- Composite of death or MI(12 months and yearly upto 5 years)
- Composite of cardiac death or MI(12 months and yearly up to 5 years)
- Target Vessel Revascularization(6 months)
- Target-lesion revascularization(12 months and yearly up to 5 years)
研究者
Seung-Jung Park
MD, PhD
CardioVascular Research Foundation, Korea
研究点 (18)
Loading locations...
相似试验
已完成
4 期
The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher StentCoronary Artery DiseaseNCT00232804Cordis Corporation639
Unknown
不适用
DXR Stent for Vascular Healing and Thrombus Formation: OCT StudyCoronary Stent OcclusionCoronary Artery DiseaseNCT02932995Chung-Ang University60
已完成
4 期
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)Coronary Artery DiseaseNCT01515228CHEOL WHAN LEE, MD, PhD.291
已完成
不适用
Evaluating the Safety and Efficacy of the Maurora® DES in ICASIntracranial ArteriosclerosisStroke (CVA) or TIANCT05719883Beijing Tiantan Hospital156
已完成
不适用
Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation LeadVentricular FibrillationVentricular TachycardiaNCT00180297Boston Scientific Corporation215